Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.
<h4>Objective</h4> <p>To assess the association between two-year changes in urine albumin-to-creatinine ratio (UACR) and the risk of clinical outcomes in type 2 diabetes (T2DM). </p> <h4>Research design and methods</h4> <p>We analyzed data from 8766 partici...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Diabetes Association
2017
|
| _version_ | 1826283008891551744 |
|---|---|
| author | Jun, M Ohkuma, T Zoungas, S Colagiuri, S Mancia, G Marre, M Matthews, D Poulter, N Williams, B Rodgers, A Perkovic, V Chalmers, J Woodward, M |
| author_facet | Jun, M Ohkuma, T Zoungas, S Colagiuri, S Mancia, G Marre, M Matthews, D Poulter, N Williams, B Rodgers, A Perkovic, V Chalmers, J Woodward, M |
| author_sort | Jun, M |
| collection | OXFORD |
| description | <h4>Objective</h4> <p>To assess the association between two-year changes in urine albumin-to-creatinine ratio (UACR) and the risk of clinical outcomes in type 2 diabetes (T2DM). </p> <h4>Research design and methods</h4> <p>We analyzed data from 8766 participants in the ADVANCE-ON study. Change in UACR was calculated from UACR measurements two years apart, classified into three groups: decrease in UACR of ≥30%, minor change and increase in UACR of ≥30%. By analyzing changes from baseline UACR groups, categorized into thirds, we repeated these analyses accounting for regression to the mean (RtM). The primary outcome was the composite of major macrovascular events, renal events and all-cause mortality; secondary outcomes were these components. Cox regression models were used to estimate hazard ratios (HRs).</p> <h4>Results</h4> <p>Over a median follow-up of 7.7 years, 2191 primary outcomes were observed. Increases in UACR over two years independently predicted a greater risk of the primary outcome (HR for ≥30% UACR increase versus minor change: 1.26, 95% confidence interval [CI]: 1.13-1.41) while a decrease in UACR was not significantly associated with lower risk (HR 0.93, 95% CI: 0.83-1.04). However, after allowing for RtM, the effect of “real” decrease in UACR on the primary outcome was found to be significant (HR 0.84, 95% CI: 0.75-0.94), whilst the estimated effect on an increase was unchanged.</p> <h4>Conclusions</h4> <p>Changes in UACR predicted changes in the risk of major clinical outcomes and mortality in T2DM, supporting the prognostic utility of monitoring albuminuria change over time.</p> |
| first_indexed | 2024-03-07T00:52:27Z |
| format | Journal article |
| id | oxford-uuid:86da4f47-1dab-4785-b604-d22199c8b5ee |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:52:27Z |
| publishDate | 2017 |
| publisher | American Diabetes Association |
| record_format | dspace |
| spelling | oxford-uuid:86da4f47-1dab-4785-b604-d22199c8b5ee2022-03-26T22:06:55ZChanges in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:86da4f47-1dab-4785-b604-d22199c8b5eeEnglishSymplectic Elements at OxfordAmerican Diabetes Association2017Jun, MOhkuma, TZoungas, SColagiuri, SMancia, GMarre, MMatthews, DPoulter, NWilliams, BRodgers, APerkovic, VChalmers, JWoodward, M <h4>Objective</h4> <p>To assess the association between two-year changes in urine albumin-to-creatinine ratio (UACR) and the risk of clinical outcomes in type 2 diabetes (T2DM). </p> <h4>Research design and methods</h4> <p>We analyzed data from 8766 participants in the ADVANCE-ON study. Change in UACR was calculated from UACR measurements two years apart, classified into three groups: decrease in UACR of ≥30%, minor change and increase in UACR of ≥30%. By analyzing changes from baseline UACR groups, categorized into thirds, we repeated these analyses accounting for regression to the mean (RtM). The primary outcome was the composite of major macrovascular events, renal events and all-cause mortality; secondary outcomes were these components. Cox regression models were used to estimate hazard ratios (HRs).</p> <h4>Results</h4> <p>Over a median follow-up of 7.7 years, 2191 primary outcomes were observed. Increases in UACR over two years independently predicted a greater risk of the primary outcome (HR for ≥30% UACR increase versus minor change: 1.26, 95% confidence interval [CI]: 1.13-1.41) while a decrease in UACR was not significantly associated with lower risk (HR 0.93, 95% CI: 0.83-1.04). However, after allowing for RtM, the effect of “real” decrease in UACR on the primary outcome was found to be significant (HR 0.84, 95% CI: 0.75-0.94), whilst the estimated effect on an increase was unchanged.</p> <h4>Conclusions</h4> <p>Changes in UACR predicted changes in the risk of major clinical outcomes and mortality in T2DM, supporting the prognostic utility of monitoring albuminuria change over time.</p> |
| spellingShingle | Jun, M Ohkuma, T Zoungas, S Colagiuri, S Mancia, G Marre, M Matthews, D Poulter, N Williams, B Rodgers, A Perkovic, V Chalmers, J Woodward, M Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. |
| title | Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. |
| title_full | Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. |
| title_fullStr | Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. |
| title_full_unstemmed | Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. |
| title_short | Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. |
| title_sort | changes in albuminuria and the risk of major clinical outcomes in diabetes results from advance on |
| work_keys_str_mv | AT junm changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT ohkumat changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT zoungass changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT colagiuris changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT manciag changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT marrem changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT matthewsd changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT poultern changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT williamsb changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT rodgersa changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT perkovicv changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT chalmersj changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon AT woodwardm changesinalbuminuriaandtheriskofmajorclinicaloutcomesindiabetesresultsfromadvanceon |